Alternative strategies for Chlamydia treatment: Promising non-antibiotic approaches

Chlamydia is an obligate intracellular bacterium where most species are pathogenic and infectious, causing various infectious diseases and complications in humans and animals. Antibiotics are often recommended for the clinical treatment of chlamydial infections. However, extensive research has shown that antibiotics may not be sufficient to eliminate or inhibit infection entirely and have some potential risks, including antibiotic resistance. The impact of chlamydial infection and antibiotic misuse should not be underestimated in public health. This study explores the possibility of new therapeutic techniques, including a review of recent studies on preventing and suppressing chlamydial infection by non-antibiotic compounds.

• Publication year

  2022

• Venue

  Frontiers in Microbiology

• Publication date

  2022-11-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fmicb.2022.987662PMID 36504792PMCID 9727249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Effects of Small Molecule Inhibitors on the Intracellular Chlamydia Infection

  2022cited by this paper
• Doxycycline: the universal treatment for anogenital chlamydia.

  2022cited by this paper
• Chlamydia pneumoniae infections and development of lung cancer: systematic review

  2022cited by this paper
• Link Between Antibiotic Persistence and Antibiotic Resistance in Bacterial Pathogens

  2022cited by this paper
• Microbiome, Metabolism, and Immunoregulation of Asthma: An American Thoracic Society and National Institute of Allergy and Infectious Diseases Workshop Report

  2022cited by this paper
• The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy

  2022cited by this paper
• Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy.

  2021cited by this paper
• The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.

  2021cited by this paper
• A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatis

  2021influential reference
• Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19

  2021cited by this paper
• Green Tea Polyphenol Catechins Inhibit Coronavirus Replication and Potentiate the Adaptive Immunity and Autophagy-Dependent Protective Mechanism to Improve Acute Lung Injury in Mice

  2021cited by this paper
• Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis.

  2021cited by this paper
• IL-10−/− Enhances DCs Immunity Against Chlamydia psittaci Infection via OX40L/NLRP3 and IDO/Treg Pathways

  2021cited by this paper
• Insights Into Host Cell Cytokines in Chlamydia Infection

  2021cited by this paper
• The Small Molecule H89 Inhibits Chlamydia Inclusion Growth and Production of Infectious Progeny

  2021cited by this paper
• Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy

  2021cited by this paper
• Optimizing Screening for Anorectal, Pharyngeal, and Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae Infections in At-Risk Adolescents and Young Adults in New Orleans, Louisiana and Los Angeles, California, United States

  2021cited by this paper
• Problems with Understanding Chlamydia trachomatis Immunology.

  2021cited by this paper
• In Vitro and In Vivo Activity of (Trifluoromethyl)pyridines as Anti-Chlamydia trachomatis Agents.

  2021cited by this paper
• Sexually Transmitted Infections

  2021cited by this paper
• An overview of genes and mutations associated with Chlamydiae species’ resistance to antibiotics

  2021cited by this paper
• Antibacterial fatty acids: An update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents

  2021cited by this paper
• mRNA vaccines for infectious diseases: principles, delivery and clinical translation

  2021cited by this paper
• Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways.

  2021cited by this paper
• Transferrins Reduce Replication of Chlamydia suis in McCoy Cells

  2021cited by this paper
• Pooling Pharyngeal, Anorectal, and Urogenital Samples for Screening Asymptomatic Men Who Have Sex with Men for Chlamydia trachomatis and Neisseria gonorrhoeae

  2020influential reference
• Human psittacosis in Japan: notification trends and differences in infection source and age distribution by gender, 2007 to 2016.

  2020cited by this paper
• Immunological regulatory effect of flavonoid baicalin on innate immune Toll-like receptors.

  2020cited by this paper
• Optimizing screening for anorectal, pharyngeal, and urogenital C. trachomatis and N. gonorrhoeae infections in at risk adolescents and young adults in New Orleans, Louisiana and Los Angeles, California, USA.

  2020cited by this paper
• Stability and antibacterial activity of Thymus daenensis L. essential oil nanoemulsion in mayonnaise.

  2020cited by this paper
• The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease

  2020cited by this paper
• A guide to vaccinology: from basic principles to new developments

  2020cited by this paper
• Psittacosis Outbreak among Workers at Chicken Slaughter Plants, Virginia and Georgia, USA, 2018

  2019cited by this paper
• Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.

  2019cited by this paper
• National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward".

  2019cited by this paper
• The Importance of Complying with Vaccination Protocols in Developed Countries: "Anti-Vax" Hysteria and the Spread of Severe Preventable Diseases.

  2019cited by this paper
• Insect Cecropins, Antimicrobial Peptides with Potential Therapeutic Applications

  2019cited by this paper
• Simultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol

  2019cited by this paper
• Levels of different cytokines in women and men with asymptomatic genital infection caused by Chlamydia.

  2019cited by this paper
• Antimicrobial peptides: new hope in the war against multidrug resistance

  2019cited by this paper
• Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species

  2019cited by this paper
• Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

  2019cited by this paper
• Tea polyphenols: application in the control of oral microorganism infectious diseases.

  2019cited by this paper
• Lactoferrin: Structure, function, denaturation and digestion

  2019cited by this paper
• Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues

  2019cited by this paper
• Antibiotics, gut microbiota, and Alzheimer’s disease

  2019cited by this paper
• High burden of chlamydia and gonorrhoea in pharyngeal, rectal and urethral sites among Thai transgender women: implications for anatomical site selection for the screening of STI

  2019cited by this paper
• Autophagy Limits Inflammasome During Chlamydia pneumoniae Infection

  2019cited by this paper
• Luteolin, a flavonoid, as an anticancer agent: A review.

  2019cited by this paper
• IL-10 Producing B Cells Dampen Protective T Cell Response and Allow Chlamydia muridarum Infection of the Male Genital Tract

  2019cited by this paper
• A Synthetic, Small, Sulfated Agent Is a Promising Inhibitor of Chlamydia spp. Infection in vivo

  2019cited by this paper
• Green Tea Catechins: Their Use in Treating and Preventing Infectious Diseases

  2018cited by this paper
• Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo

  2018cited by this paper
• No benefit of chlamydia screening in primary care?

  2018cited by this paper
• Antibacterial Free Fatty Acids and Monoglycerides: Biological Activities, Experimental Testing, and Therapeutic Applications

  2018cited by this paper
• Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases

  2018cited by this paper
• Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway

  2018cited by this paper
• Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

  2018cited by this paper
• Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects

  2018cited by this paper
• Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies.

  2018cited by this paper
• Effect of Tea Catechins on Influenza Infection and the Common Cold with a Focus on Epidemiological/Clinical Studies

  2018cited by this paper
• Immunotherapy for Chronic Hepatitis B Virus Infection

  2018cited by this paper
• Therapeutic HPV vaccines.

  2017cited by this paper
• Chlamydial Plasmid-Dependent Pathogenicity.

  2017influential reference
• Paper microfluidics for nucleic acid amplification testing (NAAT) of infectious diseases.

  2017cited by this paper
• Concordance of chlamydia infections of the rectum and urethra in same-sex male partnerships: a cross-sectional analysis

  2017cited by this paper
• Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.

  2017cited by this paper
• Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.

  2017cited by this paper
• Chlamydiae

  2017cited by this paper
• New challenges in therapeutic vaccines against HIV infection

  2017cited by this paper
• Editorial overview: Use of PK-PD for antibacterial drug development: decreasing risk and paths forward for resistant pathogens.

  2017cited by this paper
• One Face of Chlamydia trachomatis: The Infectious Elementary Body.

  2016cited by this paper
• Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides

  2016cited by this paper
• Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice

  2016cited by this paper
• Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication.

  2016cited by this paper
• Chlamydia cell biology and pathogenesis

  2016cited by this paper
• A Brief History of Vaccines Against Polio.

  2016cited by this paper
• Chlamydia pneumoniae Infection and Inflammatory Diseases.

  2016cited by this paper
• Polyphenols as Modulators of Aquaporin Family in Health and Disease

  2015cited by this paper
• Spectrum of Membrane Morphological Responses to Antibacterial Fatty Acids and Related Surfactants.

  2015cited by this paper
• Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.

  2015cited by this paper
• The Epidemiology of Chlamydia trachomatis Organism Load During Genital Infection: A Systematic Review.

  2015cited by this paper
• A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells

  2015cited by this paper
• Significant Roles Played by IL-10 in Chlamydia Infections

  2014cited by this paper
• Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist

  2014cited by this paper
• Treatment of rectal chlamydia infection may be more complicated than we originally thought.

  2014cited by this paper
• Lipopolysaccharide-Binding Alkylpolyamine DS-96 Inhibits Chlamydia trachomatis Infection by Blocking Attachment and Entry

  2014cited by this paper
• Application of DNA Chip Scanning Technology for Automatic Detection of Chlamydia trachomatis and Chlamydia pneumoniae Inclusions

  2013cited by this paper
• Sexually Transmitted Infections

  2013cited by this paper
• Host defense peptides: general overview and an update on their activity against Chlamydia spp.

  2013cited by this paper
• Lipid a biosynthesis of multidrug-resistant pathogens - a novel drug target.

  2013cited by this paper
• Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis

  2013cited by this paper
• Chlamydia-induced ReA: immune imbalances and persistent pathogens

  2012cited by this paper
• Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis

  2012cited by this paper
• Baicalin suppresses expression of TLR2/4 and NF-κB in chlamydia trachomatis–infected mice

  2012cited by this paper
• Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy

  2012cited by this paper
• Chlamydia pneumoniae: modern insights into an ancient pathogen.

  2012cited by this paper
• Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion

  2012cited by this paper
• Spider Venom Peptides for Gene Therapy of Chlamydia Infection

  2011cited by this paper
• Cytokine gene polymorphism and Chlamydia trachomatis-specific immune responses.

  2011cited by this paper

• Probiotics in Women's Health: Mechanisms, Benefits, and Potential Applications for Preventing Bacterial Vaginosis and Sexually Transmitted Diseases in Sexual Health Products

  2025cites this paper
• Bisabolane Sesquiterpenes with Anti-Chlamydial Activity Isolated from Ligularia narynensis

  2025cites this paper
• Rapid visual discrimination and quantification of multiple antibiotics based on machine learning-assisted fluorescence sensor array

  2025cites this paper
• Antibacterial effects of coniferyl alcohol-derived dehydrogenation polymer on chlamydial infection in vitro

  2025cites this paper
• Lipid nanoparticle-delivered mRNA vaccine encoding the MOMP of Chlamydia psittaci elicits protective immune responses in BALB/c mice

  2025cites this paper
• Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects

  2024cites this paper
• Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs

  2024cites this paper
• In silico design and analysis of a multiepitope vaccine against Chlamydia

  2024cites this paper
• Combination of compound screening with an animal model identifies pentamidine to prevent Chlamydia trachomatis infection

  2024cites this paper
• Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development

  2024cites this paper
• Update on the Epidemiology, Screening, and Management of Chlamydia trachomatis Infection.

  2023cites this paper